<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37333619</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-5099</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in molecular neuroscience</Title><ISOAbbreviation>Front Mol Neurosci</ISOAbbreviation></Journal><ArticleTitle>Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID.</ArticleTitle><Pagination><StartPage>1194769</StartPage><MedlinePgn>1194769</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1194769</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnmol.2023.1194769</ELocationID><Abstract><AbstractText>Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive tryptophan catabolites (TRYCATs), including kynurenine (KYN). The TRYCAT pathway has not been studied extensively in association with the physiosomatic and affective symptoms of Long COVID. In the present study, we measured serum TRY, TRYCATs, insulin resistance (using the Homeostatic Model Assessment Index 2-insulin resistance, HOMA2-IR), C-reactive protein (CRP), physiosomatic, depression, and anxiety symptoms in 90 Long COVID patients, 3-10 months after remission of acute infection. We were able to construct an endophenotypic class of severe Long COVID (22% of the patients) with very low TRY and oxygen saturation (SpO2, during acute infection), increased kynurenine, KYN/TRY ratio, CRP, and very high ratings on all symptom domains. One factor could be extracted from physiosomatic symptoms (including chronic fatigue-fibromyalgia), depression, and anxiety symptoms, indicating that all domains are manifestations of the common physio-affective phenome. Three Long COVID biomarkers (CRP, KYN/TRY, and IR) explained around 40% of the variance in the physio-affective phenome. The latter and the KYN/TRY ratio were significantly predicted by peak body temperature (PBT) and lowered SpO2 during acute infection. One validated latent vector could be extracted from the three symptom domains and a composite based on CRP, KYN/TRY, and IR (Long COVID), and PBT and SpO2 (acute COVID-19). In conclusion, the physio-affective phenome of Long COVID is a manifestation of inflammatory responses during acute and Long COVID, and lowered plasma tryptophan and increased kynurenine may contribute to these effects.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Al-Hakeim, Khairi Abed, Rouf Moustafa, Almulla and Maes.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Hakeim</LastName><ForeName>Hussein Kadhem</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Chemistry, College of Science, University of Kufa, Kufa, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khairi Abed</LastName><ForeName>Anwar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, College of Science, University of Kufa, Kufa, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouf Moustafa</LastName><ForeName>Shatha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Analysis Department, College of Pharmacy, Hawler Medical University, Erbil, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almulla</LastName><ForeName>Abbas F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maes</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyung Hee University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Mol Neurosci</MedlineTA><NlmUniqueID>101477914</NlmUniqueID><ISSNLinking>1662-5099</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">affective symptoms</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">indoleamine-2,3-dioxygenase</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">neuro-immune</Keyword><Keyword MajorTopicYN="N">neurotoxicity</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>2</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37333619</ArticleId><ArticleId IdType="pmc">PMC10272345</ArticleId><ArticleId IdType="doi">10.3389/fnmol.2023.1194769</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Jassas H. K., Al-Hakeim H. K., Maes M. (2022). Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: a nomothetic network approach. J. Affect. Disord. 297, 233&#x2013;245. doi: 10.1016/j.jad.2021.10.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.10.039</ArticleId><ArticleId IdType="pmc">PMC8541833</ArticleId><ArticleId IdType="pubmed">34699853</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hadrawi D. S., Al-Rubaye H. T., Almulla A. F., Al-Hakeim H. K., Maes M. (2022). Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to LONG COVID: a precision nomothetic approach. Acta Neuropsychiat. 297, 1&#x2013;12. doi: 10.1017/neu.2022.21</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/neu.2022.21</ArticleId><ArticleId IdType="pubmed">36134517</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H. K., Al-Rubaye H. T., Al-Hadrawi D. S., Almulla A. F., Maes M. (2023a). Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol. Psychiatry 28, 564&#x2013;578. doi: 10.1038/s41380-022-01836-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H. K., Al-Rubaye H. T., Almulla A. F., Al-Hadrawi D. S., Maes M. (2023b). Chronic fatigue, depression and anxiety symptoms in long COVID are strongly predicted by Neuroimmune and Neuro-oxidative pathways which are caused by the inflammation during acute infection. J. Clin. Med. 12:511. doi: 10.3390/jcm12020511, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020511</ArticleId><ArticleId IdType="pmc">PMC9865328</ArticleId><ArticleId IdType="pubmed">36675440</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H., Jubran A., Almulla A., Moustafa S., Maes M. (2022). Increased insulin resistance due to long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection. Braz. J. Psychiatry doi: 10.47626/1516-4446-2022-3002 [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.47626/1516-4446-2022-3002</ArticleId><ArticleId IdType="pmc">PMC10288478</ArticleId><ArticleId IdType="pubmed">36917827</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Al-Hakeim H. K., Abed M. S., Carvalho A. F., Maes M. (2020). Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways. Schizophr. Res. 222, 342&#x2013;353. doi: 10.1016/j.schres.2020.05.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2020.05.003</ArticleId><ArticleId IdType="pubmed">32467068</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Al-Hakeim H. K., Maes M. (2023). Chronic fatigue and affective symptoms in acute and long COVID are attributable to immune-inflammatory pathways. Psychiatry Clin. Neurosci. 77, 125&#x2013;126. doi: 10.1111/pcn.13514, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13514</ArticleId><ArticleId IdType="pmc">PMC9877923</ArticleId><ArticleId IdType="pubmed">36454120</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Al-Rawi K. F., Maes M., Al-Hakeim H. K. (2021). In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms. J. Affect. Disord. 287, 316&#x2013;326. doi: 10.1016/j.jad.2021.03.062, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.03.062</ArticleId><ArticleId IdType="pubmed">33812245</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Maes M. (2022). The tryptophan Catabolite or Kynurenine Pathway's role in major depression. Curr. Top. Med. Chem. 22, 1731&#x2013;1735. doi: 10.2174/1568026622666220428095250, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026622666220428095250</ArticleId><ArticleId IdType="pubmed">36321312</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Supasitthumrong T., Amrapala A., Tunvirachaisakul C., Jaleel A.-K. K. A., Oxenkrug G., et al. . (2022a). The tryptophan catabolite or kynurenine pathway in Alzheimer&#x2019;s disease: a systematic review and meta-analysis. J. Alzheimers Dis. 88, 1&#x2013;15. doi: 10.3233/JAD-220295</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220295</ArticleId><ArticleId IdType="pubmed">35786655</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Supasitthumrong T., Tunvirachaisakul C., Algon A. A. A., Al-Hakeim H. K., Maes M. (2022b). The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis. BMC Infect. Dis. 22, 1&#x2013;14. doi: 10.1186/s12879-022-07582-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07582-1</ArticleId><ArticleId IdType="pmc">PMC9284970</ArticleId><ArticleId IdType="pubmed">35840908</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Thipakorn Y., Vasupanrajit A., Tunvirachaisakul C., Oxenkrug G., Al-Hakeim H. K., et al. . (2022c). The tryptophan Catabolite or Kynurenine pathway in a major depressive episode with melancholia, psychotic features and suicidal behaviors: a systematic review and Meta-analysis. Cells 11:3112. doi: 10.3390/cells11193112, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11193112</ArticleId><ArticleId IdType="pmc">PMC9563030</ArticleId><ArticleId IdType="pubmed">36231075</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Vasupanrajit A., Tunvirachaisakul C., Al-Hakeim H. K., Solmi M., Verkerk R., et al. . (2022d). The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments. Mol. Psychiatry 27, 3679&#x2013;3691. doi: 10.1038/s41380-022-01552-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01552-4</ArticleId><ArticleId IdType="pubmed">35422466</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D. T., Hamilton F. W., Milne A., Morley A. J., Viner J., Attwood M., et al. . (2021). Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 76, 399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch J. B., Rengasamy E. R., Watson C., Jansen K., Chakraborty S., Sundaram R. D., et al. . (2022). Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun. 4:fcab297. doi: 10.1093/braincomms/fcab297, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat Methodol. 57, 289&#x2013;300. doi: 10.1111/j.2517-6161.1995.tb02031.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliddal S., Banasik K., Pedersen O. B., Nissen J., Cantwell L., Schwinn M., et al. . (2021). Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci. Rep. 11:13153. doi: 10.1038/s41598-021-92045-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaccorso S., Marino V., Biondi M., Grimaldi F., Ippoliti F., Maes M. (2002). Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J. Affect. Disord. 72, 237&#x2013;241. doi: 10.1016/s0165-0327(02)00264-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-0327(02)00264-1</ArticleId><ArticleId IdType="pubmed">12450640</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth E. S., Basran J., Lee M., Handa S., Raven E. L. (2015). Substrate oxidation by indoleamine 2, 3-dioxygenase. J. Biol. Chem. 290, 30924&#x2013;30930. doi: 10.1074/jbc.M115.695684, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.695684</ArticleId><ArticleId IdType="pmc">PMC4692220</ArticleId><ArticleId IdType="pubmed">26511316</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornand D., Toovey S., Jick S. S., Meier C. R. (2016). The risk of new onset depression in association with influenza&#x2013;a population-based observational study. Brain Behav. Immun. 53, 131&#x2013;137. doi: 10.1016/j.bbi.2015.12.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.12.005</ArticleId><ArticleId IdType="pubmed">26681501</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordeiro L., Guimaraes J., Wanner S., La Guardia R., Miranda R., Marubayashi U., et al. . (2014). Inhibition of tryptophan hydroxylase abolishes fatigue induced by central tryptophan in exercising rats. Scand. J. Med. Sci. Sports 24, 80&#x2013;88. doi: 10.1111/j.1600-0838.2012.01464.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0838.2012.01464.x</ArticleId><ArticleId IdType="pubmed">22540893</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutz E., Speirs V., Yeger H., Newman C., Wang D., Perrin D. G. (1993). Cell biology of pulmonary neuroepithelial bodies--validation of an in vitro model. I. Effects of hypoxia and Ca2+ ionophore on serotonin content and exocytosis of dense core vesicles. Anat. Rec. 236, 41&#x2013;52. doi: 10.1002/ar.1092360109, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.1092360109</ArticleId><ArticleId IdType="pubmed">8507015</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re'em Y., et al. . (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38:101019. doi: 10.1016/j.eclinm.2021.101019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C. (2022). Long COVID: current definition. Infection 50, 285&#x2013;286. doi: 10.1007/s15010-021-01696-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernstrom J., Wurtman R. (1972). Elevation of plasma tryptophan by insulin in rat. Metabolism 21, 337&#x2013;342. doi: 10.1016/0026-0495(72)90078-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0026-0495(72)90078-9</ArticleId><ArticleId IdType="pubmed">5061052</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein L. E., Leopold M. C., Huang X., Atwood C. S., Saunders A. J., Hartshorn M., et al. . (2000). 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote &#x3b1;-crystallin cross-linking by metal ion reduction. Biochemistry 39, 7266&#x2013;7275. doi: 10.1021/bi992997s, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi992997s</ArticleId><ArticleId IdType="pubmed">10852726</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Benito Ballesteros A., Yeung S. P., Liu R., Saha A., Curtis L., et al. . (2022). COVCOG 2: cognitive and memory deficits in long COVID: a second publication from the COVID and cognition study. Front. Aging Neurosci. 14:804937. doi: 10.3389/fnagi.2022.804937</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804937</ArticleId><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. (1959). The assessment of anxiety states by rating. Br. J. Med. Psychol. 32, 50&#x2013;55. doi: 10.1111/j.2044-8341.1959.tb00467.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8341.1959.tb00467.x</ArticleId><ArticleId IdType="pubmed">13638508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. (1960). A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56&#x2013;62. doi: 10.1136/jnnp.23.1.56, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.23.1.56</ArticleId><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampton T. (2016). How depressed mood may develop after viral infection. JAMA 315:2267. doi: 10.1001/jama.2016.6852</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.6852</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. . (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397, 220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanchanatawan B., Sriswasdi S., Maes M. (2019). Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia. Metab. Brain Dis. 34, 267&#x2013;282. doi: 10.1007/s11011-018-0339-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-018-0339-7</ArticleId><ArticleId IdType="pubmed">30467771</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi Z., Davoodi Z., Rabiei L., Jafari M., Kiani Dehkordi M., Marzo R. R., et al. . (2022). The potential association of COVID-19 and psychological distress and anxiety in Iran. Int. J. Epidemiol. Health Sci. 3, 1&#x2013;8. doi: 10.51757/ijehs.3.2022.254985</Citation><ArticleIdList><ArticleId IdType="doi">10.51757/ijehs.3.2022.254985</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebau C., Baltzer A., Schmidt S., Roesel C., Karreman C., Prisack J. B., et al. . (2002). Interleukin-12 and interleukin-18 induce indoleamine 2, 3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. Anticancer Res. 22, 931&#x2013;936. PMID:</Citation><ArticleIdList><ArticleId IdType="pubmed">12014674</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M. (2011a). Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 35, 664&#x2013;675. doi: 10.1016/j.pnpbp.2010.06.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2010.06.014</ArticleId><ArticleId IdType="pubmed">20599581</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M. (2011b). An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&amp;NS) pathways. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 35, 784&#x2013;794. doi: 10.1016/j.pnpbp.2010.06.023, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2010.06.023</ArticleId><ArticleId IdType="pubmed">20609377</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Al-Rubaye H. T., Almulla A. F., Al-Hadrawi D. S., Stoyanova K., Kubera M., et al. . (2022a). Lowered quality of life in long COVID is predicted by affective symptoms, chronic fatigue syndrome, inflammation and Neuroimmunotoxic pathways. Int. J. Environ. Res. Public Health 19. doi: 10.3390/ijerph191610362, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610362</ArticleId><ArticleId IdType="pmc">PMC9408685</ArticleId><ArticleId IdType="pubmed">36011997</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Galecki P., Verkerk R., Rief W. (2011a). Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2, 3-dioxygenase and lowered kynurenine aminotransferase activity. Neuroendocrinol. Lett. 32, 264&#x2013;273. PMID:</Citation><ArticleIdList><ArticleId IdType="pubmed">21712776</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Leonard B., Myint A., Kubera M., Verkerk R. (2011b). The new &#x2018;5-HT&#x2019;hypothesis of depression: cell-mediated immune activation induces indoleamine 2, 3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 35, 702&#x2013;721. doi: 10.1016/j.pnpbp.2010.12.017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2010.12.017</ArticleId><ArticleId IdType="pubmed">21185346</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Minner B., Suy E. (1991). The relationships between the availability of L-tryptophan to the brain, the spontaneous HPA-axis activity, and the HPA-axis responses to dexamethasone in depressed patients. Amino Acids 1, 57&#x2013;65. doi: 10.1007/BF00808091, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00808091</ArticleId><ArticleId IdType="pubmed">24194047</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Rachayon M., Jirakran K., Sodsai P., Klinchanhom S., Ga&#x142;ecki P., et al. . (2022b). The immune profile of major dysmood disorder: proof of concept and mechanism using the precision nomothetic psychiatry approach. Cells 11:1183. doi: 10.3390/cells11071183, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071183</ArticleId><ArticleId IdType="pmc">PMC8997660</ArticleId><ArticleId IdType="pubmed">35406747</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Rief W. (2012). Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway. Psychiatry Res. 196, 249&#x2013;243. doi: 10.1016/j.psychres.2011.09.029, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2011.09.029</ArticleId><ArticleId IdType="pubmed">22364930</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Twisk F. N. (2010). Treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a multisystem disease, should target the pathophysiological aberrations (inflammatory and oxidative and nitrosative stress pathways), not the psychosocial &#x201c;barriers&#x201d; for a new equilibrium. Patient Educ. Couns. 80, 148&#x2013;9; author reply 147. doi: 10.1016/j.pec.2010.02.017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2010.02.017</ArticleId><ArticleId IdType="pubmed">20303231</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Verkerk R., Vandoolaeghe E., Van Hunsel F., Neels H., Wauters A., et al. . (1997). Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response. Eur. Arch. Psychiatry Clin. Neurosci. 247, 154&#x2013;161. doi: 10.1007/BF03033069, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03033069</ArticleId><ArticleId IdType="pubmed">9224908</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Wauters A., Verkerk R., Demedts P., Neels H., Van Gastel A., et al. . (1996). Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism. Neuropsychopharmacology 15, 243&#x2013;251. doi: 10.1016/0893-133X(95)00181-C, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0893-133X(95)00181-C</ArticleId><ArticleId IdType="pubmed">8873107</ArticleId></ArticleIdList></Reference><Reference><Citation>McMenamy R. H., Oncley J. (1958). The specific binding of L-tryptophan to serum albumin. J. Biol. Chem. 233, 1436&#x2013;1447. doi: 10.1016/S0021-9258(18)49353-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)49353-2</ArticleId><ArticleId IdType="pubmed">13610854</ArticleId></ArticleIdList></Reference><Reference><Citation>Milaneschi Y., Allers K. A., Beekman A. T., Giltay E. J., Keller S., Schoevers R. A., et al. . (2021). The association between plasma tryptophan catabolites and depression: the role of symptom profiles and inflammation. Brain Behav. Immun. 97, 167&#x2013;175. doi: 10.1016/j.bbi.2021.07.007, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.007</ArticleId><ArticleId IdType="pubmed">34252568</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G. F., Carvalho A., Anderson G., Galecki P., Maes M. (2016). The many neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders. Curr. Pharm. Des. 22, 963&#x2013;977. doi: 10.2174/1381612822666151215102420, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612822666151215102420</ArticleId><ArticleId IdType="pubmed">26667000</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelp M. T., Kates P. A., Hunt J. T., Newitt J. A., Balog A., Maley D., et al. . (2018). Immune-modulating enzyme indoleamine 2, 3-dioxygenase is effectively inhibited by targeting its apo-form. Proc. Natl. Acad. Sci. 115, 3249&#x2013;3254. doi: 10.1073/pnas.1719190115, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1719190115</ArticleId><ArticleId IdType="pmc">PMC5879690</ArticleId><ArticleId IdType="pubmed">29531094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormstad H., Simonsen C. S., Broch L., Maes M., Anderson G., Celius E. G. (2020). Chronic fatigue and depression due to multiple sclerosis: immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways. Mult. Scler. Relat. Disord. 46:102533. doi: 10.1016/j.msard.2020.102533, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102533</ArticleId><ArticleId IdType="pubmed">33010585</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxenkrug G. F. (2007). Genetic and hormonal regulation of tryptophan&#x2013;kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann. N. Y. Acad. Sci. 1122, 35&#x2013;49. doi: 10.1196/annals.1403.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1403.003</ArticleId><ArticleId IdType="pubmed">18077563</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H. Y., Park W. B., Lee S. H., Kim J. L., Lee J. J., Lee H., et al. . (2020). Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea. BMC Public Health 20, 1&#x2013;9. doi: 10.1186/s12889-020-08726-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-08726-1</ArticleId><ArticleId IdType="pmc">PMC7224724</ArticleId><ArticleId IdType="pubmed">32410603</ArticleId></ArticleIdList></Reference><Reference><Citation>Partridge W. (1979). The role of blood-brain barrier transport of tryptophan and other amino acids in the regulation of substratelimited pathways of brain amino acid metabolism. J. Neural Transm. 15, 43&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">385809</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N. V., Briggs J., Seal S. M., Battaglini D., Fanning J., et al. . (2022). Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J. Neurol. Sci. 434:120162. doi: 10.1016/j.jns.2022.120162, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes Ocampo J., Lugo Huitr&#xf3;n R., Gonz&#xe1;lez-Esquivel D., Ugalde-Mu&#xf1;iz P., Jim&#xe9;nez-Anguiano A., Pineda B., et al. . (2014). Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. Oxidative Med. Cell. Longev. 2014, 1&#x2013;22. doi: 10.1155/2014/646909</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/646909</ArticleId><ArticleId IdType="pmc">PMC3945746</ArticleId><ArticleId IdType="pubmed">24693337</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E. D., Hishmeh L. (2021). Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ:372. doi: 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Smesam H. N., Qazmooz H. A., Khayoon S. Q., Almulla A. F., Al-Hakeim H. K., Maes M. (2022). Pathway phenotypes underpinning depression, anxiety, and chronic fatigue symptoms due to acute rheumatoid arthritis: a precision nomothetic psychiatry analysis. J. Personal. Med. 12:476. doi: 10.3390/jpm12030476, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12030476</ArticleId><ArticleId IdType="pmc">PMC8950237</ArticleId><ArticleId IdType="pubmed">35330475</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A. J., Smith R. A., Stone T. W. (2009). 5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones. Neurotox. Res. 15, 303&#x2013;310. doi: 10.1007/s12640-009-9034-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-009-9034-0</ArticleId><ArticleId IdType="pubmed">19384564</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X., Zhang Y., Zhang L., Song W., Shi L. (2018). Hypoxia enhances indoleamine 2,3-dioxygenase production in dendritic cells. Oncotarget 9, 11572&#x2013;11580. doi: 10.18632/oncotarget.24098, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.24098</ArticleId><ArticleId IdType="pmc">PMC5837754</ArticleId><ArticleId IdType="pubmed">29545920</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J. R., Husain M., Luciano S., Harrison P. J. (2021). 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 8, 416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Titze-de-Almeida R., da Cunha T. R., dos Santos Silva L. D., Ferreira C. S., Silva C. P., Ribeiro A. P., et al. . (2022). Persistent, new-onset symptoms and mental health complaints in long COVID in a Brazilian cohort of non-hospitalized patients. BMC Infect. Dis. 22, 1&#x2013;11. doi: 10.1186/s12879-022-07065-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07065-3</ArticleId><ArticleId IdType="pmc">PMC8821794</ArticleId><ArticleId IdType="pubmed">35135496</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Borst B., Peters J. B., Brink M., Schoon Y., Bleeker-Rovers C. P., Schers H., et al. . (2021). Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin. Infect. Dis. 73, e1089&#x2013;e1098. doi: 10.1093/cid/ciaa1750, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO (2021). "A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021". World Health Organization.</Citation></Reference><Reference><Citation>Wichers M. C., Koek G., Robaeys G., Verkerk R., Scharpe S., Maes M. (2005). IDO and interferon-&#x3b1;-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol. Psychiatry 10, 538&#x2013;544. doi: 10.1038/sj.mp.4001600, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mp.4001600</ArticleId><ArticleId IdType="pubmed">15494706</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S. J. (2021). Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. Ther. 53, 737&#x2013;754. doi: 10.1080/23744235.2021.1924397, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuwiler A., Oldendorf W., Geller E., Braun L. (1977). Effect of albumin binding and amino acid competition on tryptophan uptake into BRAIN 1. J. Neurochem. 28, 1015&#x2013;1023. doi: 10.1111/j.1471-4159.1977.tb10664.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1977.tb10664.x</ArticleId><ArticleId IdType="pubmed">16985</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachrisson O., Regland B., Jahreskog M., Kron M., Gottfries C. G. (2002). A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). J. Psychosom. Res. 52, 501&#x2013;509. doi: 10.1016/s0022-3999(01)00315-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3999(01)00315-4</ArticleId><ArticleId IdType="pubmed">12069875</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>